Recent advances in bacteriology and the study of the infections (Record no. 28029)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01882nam a2200193#a 4500 |
| 001 - CONTROL NUMBER | |
| control field | 28029 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | NIH |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240614021356.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 240614s1929 xx 000 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NIH |
| Language of cataloging | eng |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Dible, James Henry, |
| Dates associated with a name | 1889- |
| 245 #0 - TITLE STATEMENT | |
| Title | Recent advances in bacteriology and the study of the infections |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 1929 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | viii, 363 p.: |
| Other physical details | illus; |
| Dimensions | 21cm |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Rapid identification (ID) and antimicrobial susceptibility testing (AST) of the causative agent(s) of bloodstream infections (BSIs) are essential for the prompt administration of an effective antimicrobial therapy, which can result in clinical and financial benefits. Immediately after blood sampling, empirical antimicrobial therapy, chosen on clinical and epidemiological data, is administered. When ID and AST results are available, the clinician decides whether to continue or streamline the antimicrobial therapy, based on the results of the in vitro antimicrobial susceptibility profile of the pathogen. The aim of the present study is to review and discuss the experimental data, advantages, and drawbacks of recently developed technological advances of culture-based and molecular methods for the diagnosis of BSI (including mass spectrometry, magnetic resonance, PCR-based methods, direct inoculation methods, and peptide nucleic acid fluorescence in situ hybridization), the understanding of which could provide new perspectives to improve and fasten the diagnosis and treatment of septic patients. Although blood culture remains the gold standard to diagnose BSIs, newly developed methods can significantly shorten the turnaround time of reliable microbial ID and AST, thus substantially improving the diagnostic yield. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Bacteriology |
| -- | Communicable Diseases |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://repository.nih.gov.my/handle/123456789/240">https://repository.nih.gov.my/handle/123456789/240</a> |
| Materials specified | Repository |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | Reference |
No items available.